Case Studies
 |
Venturing Into the Ear FrontierOtonomy’s genesis has all the makings of a biopharmaceutical legend. Jay Lichter, Ph.D., managing director of Avalon Ventures, was driving down Prospect Street in La Jolla, Calif. one afternoon in January 2008 when he was struck not by a great entrepreneurial idea, but rather an unbearable dizziness. Read More |
 |
Anatomy of a Biopharmaceutical DealIt was the perspicacity of team members J. Gordon Foulkes and Niall O’Donnell in shepherding pharmaceuticals from gene discovery to clinical trials that attracted entrepreneur Nicholas Dean, Ph.D., to partnering with RiverVest. Read More |
 |
VC Partner as Sounding BoardExperience, steady leadership, a willingness to drive change, and a deep understanding of the growing pains of a start-up” these are a few of the benefits CEO Joe Army cites when discussing the role of Salient’s Chairman of the Board Jay Schmelter, who is also a managing director of RiverVest. Read More |
 |
RiverVest’s Founding Role Launches Device CompanyWhat happens when a VC Fund’s managing director with interventional cardiology expertise is asked by a fellow entrepreneur with a track record of multibillion-dollar inventions to help build a company around a groundbreaking interventional cardiology device? Read More |
